Inactivating CUX1 mutations promote tumorigenesis.
Saved in:
| Title: | Inactivating CUX1 mutations promote tumorigenesis. |
|---|---|
| Authors: | Wong CC; 1] Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. [2] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK., Martincorena I; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Rust AG; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Rashid M; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Alifrangis C; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Alexandrov LB; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Tiffen JC; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Kober C; 1] Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. [2]., Green AR; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, UK. [3] Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK., Massie CE; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, UK. [3] Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK., Nangalia J; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, UK. [3] Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK., Lempidaki S; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., Döhner H; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Döhner K; Department of Internal Medicine III, University of Ulm, Ulm, Germany., Bray SJ; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK., McDermott U; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Papaemmanuil E; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Campbell PJ; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK., Adams DJ; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. |
| Corporate Authors: | Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium |
| Source: | Nature genetics [Nat Genet] 2014 Jan; Vol. 46 (1), pp. 33-8. Date of Electronic Publication: 2013 Dec 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 24316979 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Inactivating CUX1 mutations promote tumorigenesis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wong+CC%22">Wong CC</searchLink>; 1] Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. [2] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Martincorena+I%22">Martincorena I</searchLink>; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Rust+AG%22">Rust AG</searchLink>; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Rashid+M%22">Rashid M</searchLink>; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Alifrangis+C%22">Alifrangis C</searchLink>; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Alexandrov+LB%22">Alexandrov LB</searchLink>; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Tiffen+JC%22">Tiffen JC</searchLink>; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kober+C%22">Kober C</searchLink>; 1] Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. [2].<br /><searchLink fieldCode="AU" term="%22Green+AR%22">Green AR</searchLink>; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, UK. [3] Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Massie+CE%22">Massie CE</searchLink>; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, UK. [3] Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Nangalia+J%22">Nangalia J</searchLink>; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, UK. [3] Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Lempidaki+S%22">Lempidaki S</searchLink>; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Döhner+H%22">Döhner H</searchLink>; Department of Internal Medicine III, University of Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Döhner+K%22">Döhner K</searchLink>; Department of Internal Medicine III, University of Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Bray+SJ%22">Bray SJ</searchLink>; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22McDermott+U%22">McDermott U</searchLink>; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Papaemmanuil+E%22">Papaemmanuil E</searchLink>; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Campbell+PJ%22">Campbell PJ</searchLink>; 1] Department of Haematology, University of Cambridge, Hills Road, Cambridge, UK. [2] The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Adams+DJ%22">Adams DJ</searchLink>; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Chronic+Myeloid+Disorders+Working+Group+of+the+International+Cancer+Genome+Consortium%22">Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229216904%22">Nature genetics</searchLink> [Nat Genet] 2014 Jan; Vol. 46 (1), pp. 33-8. <i>Date of Electronic Publication: </i>2013 Dec 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Co%22">Nature Pub. Co </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9216904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-1718 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210614036%22">10614036 </searchLink><i>NLM ISO Abbreviation: </i>Nat Genet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24316979 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/ng.2846 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 33 Titles: – TitleFull: Inactivating CUX1 mutations promote tumorigenesis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wong CC – PersonEntity: Name: NameFull: Martincorena I – PersonEntity: Name: NameFull: Rust AG – PersonEntity: Name: NameFull: Rashid M – PersonEntity: Name: NameFull: Alifrangis C – PersonEntity: Name: NameFull: Alexandrov LB – PersonEntity: Name: NameFull: Tiffen JC – PersonEntity: Name: NameFull: Kober C – PersonEntity: Name: NameFull: Green AR – PersonEntity: Name: NameFull: Massie CE – PersonEntity: Name: NameFull: Nangalia J – PersonEntity: Name: NameFull: Lempidaki S – PersonEntity: Name: NameFull: Döhner H – PersonEntity: Name: NameFull: Döhner K – PersonEntity: Name: NameFull: Bray SJ – PersonEntity: Name: NameFull: McDermott U – PersonEntity: Name: NameFull: Papaemmanuil E – PersonEntity: Name: NameFull: Campbell PJ – PersonEntity: Name: NameFull: Adams DJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2014 Jan Type: published Y: 2014 Identifiers: – Type: issn-electronic Value: 1546-1718 Numbering: – Type: volume Value: 46 – Type: issue Value: 1 Titles: – TitleFull: Nature genetics Type: main |
| ResultId | 1 |